Sida Qin1, Boxiang Zhang2, Chongwen Xu2, Shuo Li2, Xifang Wang2, Xin Sun2, Peili Wang2, Hong Ren2
1Department of Thoracic
Surgery, First Affiliated Hospital, School of Medicine, Xi’an Jiaotong
University, 2School of Medicine,
First Affiliated Hospital
Objective:Hyperthermia induces cancer cellapoptosis,
but its molecular mechanisms remain unclear. Here, we investigated the role of
Survivin in hyperthermia induced apoptosis in esophageal cancer. Method: EC109
cells were treated with different temperatures. Cell viability was detected by
MTT assay, and apoptosis was measured by flow cytometry. Cell transfection,
western blotting, and immunoprecipitations were used to measure the mechanisms
of hyperthermia. Survivin expression was detected by immunehisto-
chemistry
in esophageal cancer patients, and its correlations with clinicopathological
features and prognosis were analyzed by Kaplan–Meier curves, log-rank tests,
and Cox regression models. Result: During treatment with hyperthermia,
EC109 cell viability was inhibited, and necrosis was increased in a
temperature-dependent manner. However, the apoptotic rate reached its peak at
43℃.
The hyperthermia-induced apoptosis was due to the inhibition of Survivin and
the activation of Caspase-3. Subsequently, we discovered that over-expression
of Survivin inhibited the activation of Caspase-3 and hyperthermia-induced
apoptosis, but this inhibition was reversed in the absence of XIAP.
Immunoprecipitations showed that Survivin did not directly bind to Caspase-3,
but XIAP interacted with both Survivin and Caspase-3. Finally, we found
Survivin was expressed at higher levels in esophageal cancer tissues than in
normal tissues, and its high expression was correlated with poor prognosis. Conclusion:Hyperthermia decreases the expression of Survivin, prevents its binding to
XIAP, inhibits Caspase-3 activation, and induces apoptosis. Due to its correlation
with poor prognosis, Survivin might be an essential target for hyperthermia in
the treatment of esophageal cancer.
Key
Words: Hyperthermia Survivin esophageal cancer
Copyright © 1998 - 2024 Chinese Society of Clinical Oncology(CSCO). All Rights Reserved
Contact Us
EMAIL:office@csco.org.cn
international@csco.org.cn
Phone:86(10)67726451 (Beijing)
86(25)84547290 (Nanjing)